Several new findings on the how the virus’ cell entry tools operate could expedite the design of vaccines, antibodies, antivirals and other therapeutics.
However, a third of patients with Physician Orders for Life Sustaining Treatment, which documented their choices for interventions, received care they had specified against.
Protein molecule design, citizen science, human chimerism, DNA privacy, sex-trafficked youth, and Mycoplasma genitalium are among areas researchers will discuss.
The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is being created with $4 million in matching funds from the National Institutes of Health.
